Journal article

Severe acute respiratory syndrome coronavirus 2 as a potential cause of type 1 diabetes facilitated by spike protein receptor binding domain attachment to human islet cells: An illustrative case study and experimental data

N Venkatesh, N Astbury, MC Thomas, CJ Rosado, E Pappas, B Krishnamurthy, RJ MacIsaac, TWH Kay, HE Thomas, DN O'Neal

Diabetic Medicine | WILEY | Published : 2021

Abstract

Aims: Aim of this study is to report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, responsible for coronavirus disease 2019 (COVID-19), as a possible cause for type 1 diabetes by providing an illustrative clinical case of a man aged 45 years presenting with antibody-negative diabetic ketoacidosis post-recovery from COVID-19 pneumonia and to explore the potential for SARS-CoV-2 to adhere to human islet cells. Methods: Explanted human islet cells from three independent solid organ donors were incubated with the SARS-CoV-2 spike protein receptor biding domain (RBD) fused to a green fluorescent protein (GFP) or a control-GFP, with differential adherence established by f..

View full abstract

Grants

Awarded by State Government of Victoria


Funding Acknowledgements

UThis work was funded by the National Health and Medical Research Council of Australia (GNT1126237 and GNT1150425). The St. Vincent's Institute receives support from the Operational Infrastructure Support Scheme of the Government of Victoria, Australia.